Close

News

Cancer Vaccine Redesign – A Transformation In The Making

Researchers at Northwestern University's International Institute for Nanotechnology (IIN) have devised a novel method for dramatically increasing the potency of practically any vaccine. The researchers used chemistry and nanotechnology to alter the structural placement of adjuvants and antigens on...

RMAT Status Given To Cardiac Gene Therapy – A First From FDA

The Regenerative Medicine Advanced Therapies designation of RP-A501, which happens to be an adeno-associated virus-based gene therapy when it comes to the treatment of Danon disease, has been granted by the US Food and Drug Administration. According to Dr. Gaurav...

4 Factors That Pharma Supply Chains Need To Address Swiftly

The post-pandemic future of healthcare has compelled one to re-evaluate the supply chain from end-to-end. Be it new technologies, shortened clinical trials, next-gen medical innovations, digitization, or risk management, all have and are going to set new benchmarks and redefine...

3 Life Sciences Innovation Factors To Watch Out For In 2023

In 2023, there are going to be numerous factors that will influence the life science sector, in turn forcing leaders to re-evaluate existing practises and put in a lot of investment when it comes to innovation. Climate change, COVID-19...

Pharma Solutions Launches AI-based Venture Unit

Pharma Solutions, a leading provider of compliance services in the life sciences industry, announced the establishment of a new corporate venture unit and product suite, LighthouseAI. The goal of LighthouseAI is to solve compliance with a first-mover, AI-powered SaaS product...

BD Introduces High-Throughput Single-Cell Multiomics Platform to Expand Scope of Scientific Discovery

BD, a leading global medical technology company, announced a new instrument for single-cell multiomics analysis that will enable scientists to run high-throughput studies without sacrificing sample integrity – potentially accelerating time to discovery across a wide range of disciplines...

SK bioscience Establishes Songdo Research & Process Development Center

SK bioscience, a global vaccine and biotech company that promotes human health from prevention to cure across the globe, has established the Songdo Global Research & Process Development Center (The R&PD Center), in Songdo, Korea. The R&PD Center is scheduled...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read